Andrew King
Family Medicine · Freehold, NJNPI 1932588803
Payments from drug & device makers
Across 183 payments — averaging $15.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$588
- Amgen$418
- Novo Nordisk$414
- AstraZeneca$222
- Lilly USA, LLC$203
- Boehringer Ingelheim$181
- plus $896 from 20 others
What the payments were for
- Food & beverage$2,90799%
- Education$151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 32 | $588 |
| Amgen(2 entities) | 25 | $418 |
| Novo Nordisk | 30 | $414 |
| AstraZeneca(2 entities) | 15 | $222 |
| Lilly USA, LLC | 14 | $203 |
| Boehringer Ingelheim | 10 | $181 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $119 |
| Amarin Pharma, Inc. | 8 | $114 |
| Pfizer | 5 | $74 |
| Astellas Pharma US Inc | 5 | $69 |
| Johnson & Johnson | 5 | $64 |
| Akcea Therapeutics, Inc. | 1 | $61 |
| Kowa Pharmaceuticals America, Inc. | 4 | $55 |
| Dynavax Technologies Corporation | 3 | $45 |
| Nestle Healthcare Nutrition Inc. | 2 | $42 |
| Merck | 3 | $39 |
| GSK | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $28 |
| Exact Sciences | 1 | $28 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Esperion Therapeutics, Inc. | 2 | $25 |
| Teva Pharmaceuticals USA, Inc. | 2 | $23 |
| Ironwood Pharmaceuticals, Inc | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $13 |
| Bausch Health US, LLC | 1 | $12 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
How this compares
$2,922 in reported general payments places this provider in the 80th percentile of 2,084 family medicine providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 12 | $36,043 |
| LinzessLinaclotide | 14 | $22,729 |
| EliquisApixaban | 22 | $22,516 |
| JardianceEmpagliflozin | 14 | $20,371 |
| MounjaroTirzepatide | 11 | $16,538 |
| FarxigaDapagliflozin Propanediol | 14 | $15,631 |
| MyrbetriqMirabegron | 11 | $10,226 |
| XareltoRivaroxaban | 13 | $7,367 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 41 | $3,901 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 154 | $3,398 |
| Gabapentin | 111 | $1,477 |
| Duloxetine Hcl | 60 | $1,334 |
| Hydroxyzine Hcl | 27 | $624 |
| Methylprednisolone | 63 | $604 |
| Rosuvastatin Calcium | 84 | $598 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $203 | $52,58123 claims |
| AbbVieLinzess | $588 | $22,72914 claims |
| PfizerEliquis | $74 | $22,51622 claims |
| Boehringer IngelheimJardiance | $181 | $20,37114 claims |
| AstraZenecaFarxiga | $222 | $15,63114 claims |
| Astellas Pharma US IncMyrbetriq | $69 | $10,22611 claims |
| Johnson & JohnsonXarelto | $64 | $7,36713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,084 family medicine providers in New Jersey.
Other family medicine in Freehold
- Howard HassmanClementon$47.1M
- Matthew HongNorth Cape May$15.3M
- Rubaba HussainClark$3.8M
- Gaurang BrahmbhattHoboken$2.6M
- Michael DobrowClifton$2.1M
- Mikhail VarshavskiChatham$1.4M
- Amit BhalodiaCamden$707K
- Jennifer AmicoNew Brunswick$627K
- Janet ColeFar Hills$466K
- Matthew PintoMarlton$239K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.